Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Label Printing and Verification for Injectable Products – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Label Printing and Verification for Injectable Products – V 2.0

Standard Operating Procedure for Label Printing and Verification for Injectable Products


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/092/2025
Supersedes SOP/SIM/092/2022
Page No. Page 1 of 12
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP provides a systematic approach for printing and verification of labels used for injectable products to ensure correct identification, traceability, and regulatory compliance throughout the packaging process.

2. Scope

This SOP is applicable to all primary

and secondary label printing, review, approval, and verification activities carried out in the sterile injectable manufacturing and packaging departments.

3. Responsibilities

  • Packaging Operator: Responsible for printing labels as per batch requirements and specifications.
  • QA Officer: To verify label accuracy, documentation, and reconciliation.
  • Production Supervisor: To authorize and oversee label printing process.
See also  Sterile Injectable Manufacturing: SOP for Operation of Filling Machines for Injections - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring label printing and verification is carried out as per SOP, and any deviations are documented and investigated appropriately.

5. Procedure

5.1 Preparation for Label Printing

  1. Receive approved artwork and label specifications from QA/Regulatory Affairs.
  2. Ensure label printer is validated and calibrated.
  3. Use blank labels stored in controlled conditions, ensuring batch segregation.
  4. Record issuance of blank labels in Label Issuance Log (Annexure-1).

5.2 Label Printing

  1. Login to the label printing software with authorized credentials.
  2. Select correct label template based on product name, strength, dosage form, and pack size.
  3. Enter batch number, manufacturing date, expiry date, and product code as per BMR.
  4. Print a test label and get it verified by QA before bulk printing.
  5. Print labels as per batch size, including overages as per approved policy.
See also  Quality Control: SOP for Analyzing Residual Solvents in Injectable Formulations - V 2.0

5.3 Label Verification

  1. QA personnel shall cross-verify 100% of the first 10 printed labels for accuracy.
  2. Random sampling (minimum 10%) of the remaining labels shall be done for quality check.
  3. Label Verification Record (Annexure-2) shall be filled and signed.
  4. Defective or excess labels must be recorded and destroyed as per SOP/SIM/096/2025.

5.4 Label Reconciliation and Storage

  1. At end of batch, unused labels must be counted, recorded, and destroyed in QA presence.
  2. Update the Label Reconciliation Log (Annexure-3).
  3. Ensure batch-specific segregation to avoid mix-up risks.
  4. Store labels securely until use or destruction.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record

7. Documents

  1. Label Issuance Log – Annexure-1
  2. Label Verification Record – Annexure-2
  3. Label Reconciliation Log – Annexure-3

8. References

  • WHO GMP Guidelines – Labeling of Pharmaceutical Products
  • ICH Q8 – Pharmaceutical Development
  • 21 CFR 211.122 – Labeling Requirements
See also  Sterile Injection Manufacturing: SOP for Use of Automated Labeling Machines in Packing Lines - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Label Issuance Log

Date Batch No. Product Label Qty Issued Issued By
18/06/2025 INJ/0923 Ceftriaxone Injection 10,500 Rajesh Kumar

Annexure-2: Label Verification Record

Label Type Batch No. Verified Items Status Checked By
Primary INJ/0923 Batch No., Mfg. Date, Exp. Date Correct Sunita Reddy

Annexure-3: Label Reconciliation Log

Batch No. Issued Used Returned Destroyed Remarks
INJ/0923 10,500 10,000 300 200 As per SOP

Revision History

Revision Date Revision No. Details Reason Approved By
20/04/2022 1.0 Initial version New SOP QA Head
18/06/2025 2.0 Improved QA verification protocol Annual review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Analytical Method Development: SOP for DLS Method for Nanoparticle Size Analysis – V 2.0
Next Post: Biosimilars: SOP for Chromatography Column Cleaning Before Reuse – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version